232 related articles for article (PubMed ID: 10793058)
21. Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphoma.
Debliquis A; Baseggio L; Bouyer S; Guy J; Garnache-Ottou F; Genevieve F; Mayeur-Rousse C; Letestu R; Chapuis N; Harrivel V; Bennani H; Lachot S; Loosveld M; Nicolino-Brunet C; Pérès M; Roussel M; Veyrat-Masson R; Jacob MC; Drenou B
Cytometry B Clin Cytom; 2021 Jul; 100(4):488-496. PubMed ID: 32803917
[TBL] [Abstract][Full Text] [Related]
22. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21.
Wang Y; Gu X; Zhang G; Wang L; Wang T; Zhao Y; Zhang X; Zhou Y; Kadin M; Tu P
Blood; 2014 May; 123(22):3452-61. PubMed ID: 24747435
[TBL] [Abstract][Full Text] [Related]
23. CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.
Chen R; Hou J; Newman E; Kim Y; Donohue C; Liu X; Thomas SH; Forman SJ; Kane SE
Mol Cancer Ther; 2015 Jun; 14(6):1376-84. PubMed ID: 25840583
[TBL] [Abstract][Full Text] [Related]
24. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
Buchan SL; Al-Shamkhani A
PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
[TBL] [Abstract][Full Text] [Related]
25. Increased expression and activation of CD30 induce apoptosis in human blood eosinophils.
Berro AI; Perry GA; Agrawal DK
J Immunol; 2004 Aug; 173(3):2174-83. PubMed ID: 15265955
[TBL] [Abstract][Full Text] [Related]
26. Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.
Jung W; Krueger S; Renner C; Gause A; Sahin U; Trümper L; Pfreundschuh M
Mol Immunol; 1994 Dec; 31(17):1329-34. PubMed ID: 7527901
[TBL] [Abstract][Full Text] [Related]
27. CD30 is required for activation of a unique subset of interleukin-17A-producing γδ T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection.
Guo Y; Sun X; Shibata K; Yamada H; Muta H; Podack ER; Yoshikai Y
Infect Immun; 2013 Oct; 81(10):3923-34. PubMed ID: 23918785
[TBL] [Abstract][Full Text] [Related]
28. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
Bisig B; de Reyniès A; Bonnet C; Sujobert P; Rickman DS; Marafioti T; Delsol G; Lamant L; Gaulard P; de Leval L
Haematologica; 2013 Aug; 98(8):1250-8. PubMed ID: 23716562
[TBL] [Abstract][Full Text] [Related]
29. Clinical Implications of CD30 Expression in Aggressive B-Cell Lymphomas.
Malysz J; Erdman P; Klapper J; Zhu J; Creer M; Bayerl MG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):429-33. PubMed ID: 27521276
[TBL] [Abstract][Full Text] [Related]
30. CD30: from basic research to cancer therapy.
Muta H; Podack ER
Immunol Res; 2013 Dec; 57(1-3):151-8. PubMed ID: 24233555
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.
Sotlar K; Cerny-Reiterer S; Petat-Dutter K; Hessel H; Berezowska S; Müllauer L; Valent P; Horny HP
Mod Pathol; 2011 Apr; 24(4):585-95. PubMed ID: 21186345
[TBL] [Abstract][Full Text] [Related]
32. Infection with parapoxvirus induces CD30-positive cutaneous infiltrates in humans.
Rose C; Starostik P; Bröcker EB
J Cutan Pathol; 1999 Nov; 26(10):520-2. PubMed ID: 10599944
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene.
Croager EJ; Gout AM; Abraham LJ
Am J Pathol; 2000 May; 156(5):1723-31. PubMed ID: 10793083
[TBL] [Abstract][Full Text] [Related]
34. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.
Falini B; Pileri S; Pizzolo G; Dürkop H; Flenghi L; Stirpe F; Martelli MF; Stein H
Blood; 1995 Jan; 85(1):1-14. PubMed ID: 7803786
[No Abstract] [Full Text] [Related]
35. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation.
Bengtsson A; Johansson C; Linder MT; Halldén G; van der Ploeg I; Scheynius A
J Leukoc Biol; 1995 Dec; 58(6):683-9. PubMed ID: 7499966
[TBL] [Abstract][Full Text] [Related]
36. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
[TBL] [Abstract][Full Text] [Related]
37. Can serum soluble CD23 or CD30 predict the occurrence of lymphoma in HIV-infected patients?
Jarrin I; Boval B; Mazeron MC; Simoneau G; Magnier JD; Green A; Andreoli A; Bergmann JF; Sellier P
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):e58-61. PubMed ID: 21860351
[No Abstract] [Full Text] [Related]
38. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
Nakashima M; Uchimaru K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
[TBL] [Abstract][Full Text] [Related]
39. How I treat primary cutaneous CD30
Shinohara MM; Shustov A
Blood; 2019 Aug; 134(6):515-524. PubMed ID: 31164331
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2.
Siegmund T; Armitage N; Wicker LS; Peterson LB; Todd JA; Lyons PA
Diabetes; 2000 Sep; 49(9):1612-6. PubMed ID: 10969850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
